[1]
“Efficacy Of Loralatinib After Combination With Alectinib Central Lung Disease In One Patient In Kinase-Positive Anaplastic Lymphoma Small Cell Lung Cancer: A Case Report”, Clinical and Medical Case Reports, vol. 2, no. 01, pp. 31–34, Jan. 2022, Accessed: Jan. 23, 2025. [Online]. Available: https://currentopinion.info/index.php/cmcr/article/view/76